Latest News and Press Releases
Want to stay updated on the latest news?
-
In data presented at SABCS23, DCISionRT changed radiation therapy decisions in 41% of DCIS patients
-
PreludeDx to Present Data for a Novel Molecular Biosignature to Predict Radiation Therapy Benefit in Early-Stage Invasive Breast Cancer at the 2023 SABCS
-
PreludeDx today announced that data will be presented in two separate poster presentations at the 2023 San Antonio Breast Cancer Symposium (SABCS).